2. GPCR/G Protein Neuronal Signaling Apoptosis PI3K/Akt/mTOR
  3. Cholecystokinin Receptor Apoptosis PI3K Akt
  4. Sincalide ammonium

Sincalide ammonium  (Synonyms: Cholecystokinin octapeptide ammonium; CCK-8 ammonium; SQ19844 ammonium)

Cat. No.: HY-P0093A Purity: 99.21%
COA
SDS
Handling Instructions Technical Support

Sincalide ammonium (Cholecystokinin octapeptide ammonium, CCK-8 ammonium) is a rapid-acting amino acid polypeptide hormone analogue of cholecystokinin (CCK) for intravenous use in postevacuation cholecystography. Sincalide ammonium is a major bioactive segment of CCK that retains most of the biological activities of CCK. CCK‐8 can promote gallbladder contraction by injection and helps diagnose gallbladder and pancreas disorders. Sincalide ammonium can increase bile secretion, cause the gallbladder to contract and relax the sphincter of Oddi, resulting in bile drainage into the duodenum. Sincalide ammonium is a major bioactive segment of CCK that retains most of the biological activities of CCK.

For research use only. We do not sell to patients.

Custom Peptide Synthesis

CAS No. : 70706-98-8

Size Price Stock Quantity
1 mg In-stock
5 mg In-stock
10 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 4 publication(s) in Google Scholar

Other Forms of Sincalide ammonium:

Sincalide ammonium Related Antibodies

Top Publications Citing Use of Products
Bio/Physico-chemical Assay
Cell Imaging/Staining
RT-PCR
Cell Proliferation/Viability Assay

    Sincalide ammonium purchased from MedChemExpress. Usage Cited in: J Gene Med. 2025 Dec;27(12):e70063.  [Abstract]

    Sincalide (Cholecystokinin; CCK) increased the expression of IL-6, TNF-α, and IL-1β in 266-6 cells.

    Sincalide ammonium purchased from MedChemExpress. Usage Cited in: Antioxidants (Basel). 2022 Dec 31;12(1):100.

    After transfection with GPX4 siRNA, mouse pancreatic acinar carcinoma 266-6 cells were treated with Sincalide (Cholecystokinin; CCK) (5 μM; 6 h), and lipid reactive oxygen species (ROS) levels and the extent of cell death were determined.

    Sincalide ammonium purchased from MedChemExpress. Usage Cited in: Immunogenetics. 2023 Feb;75(1):17-25.  [Abstract]

    Sincalide (CCK-8) (10 μL; 37 ℃; 2 h) was used to evaluate the proliferative ability of LUAD cells.

    Sincalide ammonium purchased from MedChemExpress. Usage Cited in: Immunogenetics. 2023 Feb;75(1):17-25.  [Abstract]

    Sincalide (CCK-8) (10 μL; 37 ℃; 2 h) was used to illustrate that si-IL4I1 + RO8191 had the ability to reverse the restraining impact of si-IL4I1 on LUAD cell proliferation.

    Sincalide ammonium purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2019 Aug:116:109001.  [Abstract]

    The OATP superfamily blocker Sincalide (SIN) (20 μM; 2 h) blocked Caba-780 uptake in renal cell carcinoma (RCC) cells.

    View All Cholecystokinin Receptor Isoform Specific Products:

    View All Isoforms
    CCKAR CCKBR

    View All PI3K Isoform Specific Products:

    View All Isoforms
    PI3Kα PI3Kβ PI3Kγ PI3Kδ PI3KC2α PI3KC2β PI3KC2γ Vps34 PI3K PI3KC3 p120γ

    View All Akt Isoform Specific Products:

    View All Isoforms
    Akt Akt1 Akt2 Akt3

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Sincalide ammonium (Cholecystokinin octapeptide ammonium, CCK-8 ammonium) is a rapid-acting amino acid polypeptide hormone analogue of cholecystokinin (CCK) for intravenous use in postevacuation cholecystography. Sincalide ammonium is a major bioactive segment of CCK that retains most of the biological activities of CCK. CCK‐8 can promote gallbladder contraction by injection and helps diagnose gallbladder and pancreas disorders. Sincalide ammonium can increase bile secretion, cause the gallbladder to contract and relax the sphincter of Oddi, resulting in bile drainage into the duodenum. Sincalide ammonium is a major bioactive segment of CCK that retains most of the biological activities of CCK[1][2][3].

    In Vitro

    Sincalide ammonium (Cholecystokinin octapeptide ammonium, CCK-8 ammonium), as a novel cardiovascular hormone, has a significant inhibitory effect on myocardial fibrosis in noninfarcted areas. Sincalide ammonium also plays a positive role in fighting inflammation, apoptosis and collagen deposition. CCK‐8 (ammonium) protects H9c2 cardiomyoblasts from Ang II‐induced apoptosis partly via activation of the CCK1 receptor and the phosphatidyqinositol‐3 kinase/protein kinase B (PI3K/Akt) signaling pathway[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Sincalide ammonium Related Antibodies

    Cell Viability Assaysup>[3]

    Cell Line: H9c2 cells
    Concentration: 0.001, 0.01, 0.1, 1, 10, or 100 μmol/L
    Incubation Time: 24 h
    Result: Attenuated Ang II‐induced toxicity in H9c2 cells

    Apoptosis Analysis[3]

    Cell Line: H9c2 cells
    Concentration: 0.001, 0.01, 0.1, 1, 10, or 100 μmol/L
    Incubation Time: 24 h
    Result: Decreased apoptotic cells, and prevented Ang II‐induced cytotoxicity that involves modulation of the PI3K/Akt pathway.

    Western Blot Analysis[3]

    Cell Line: H9c2 cells
    Concentration: 0.001, 0.01, 0.1, 1, 10, or 100 μmol/L
    Incubation Time: 24 h
    Result: Expressed the protein and mRNAs of CCK and both its receptors in H9c2 cells.

    RT-PCR[3]

    Cell Line: H9c2 cells
    Concentration: 0.001, 0.01, 0.1, 1, 10, or 100 μmol/L
    Incubation Time: 24 h
    Result: Increased the protein and mRNA expression levels of CCK and decreased CCK 1 receptor expression levels at both the protein and mRNA levels with Ang II stimulation markedly.
    In Vivo

    Sincalide ammonium (Cholecystokinin octapeptide ammonium, CCK-8 ammonium) alleviates fibrosis in the noninfarcted regions and delay the left ventricular remodeling and the progress of heart failure in a MI rat model[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: MI rat model[4]
    Dosage: 50 μg/kg
    Administration: i.p.; 50 μg/kg/d; for 4 weeks
    Result: Had significant inhibitory effect on myocardial fibrosis in noninfarcted areas.
    Clinical Trial
    Molecular Weight

    1160.30

    Formula

    C49H65N11O16S3
    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    Sequence Shortening

    D-{SO3H-Tyr}-MGWMDF-NH2
    Shipping

    Room temperature in continental US; may vary elsewhere.
    Storage

    Sealed storage, away from moisture and light, under nitrogen

    Powder -80°C 2 years
    -20°C 1 year

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)

    Solvent & Solubility
    In Vitro: 

    H2O : 33.33 mg/mL (28.73 mM; Need ultrasonic)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 0.8618 mL 4.3092 mL 8.6185 mL
    5 mM 0.1724 mL 0.8618 mL 1.7237 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
    Purity & Documentation

    Purity: 99.21%

    SDS (252 KB)

    COA (251 KB) RP-HPLC (321 KB) MS (72 KB)

    Handling Instructions (2659 KB)
    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    H2O 1 mM 0.8618 mL 4.3092 mL 8.6185 mL 21.5462 mL
    5 mM 0.1724 mL 0.8618 mL 1.7237 mL 4.3092 mL
    10 mM 0.0862 mL 0.4309 mL 0.8618 mL 2.1546 mL
    15 mM 0.0575 mL 0.2873 mL 0.5746 mL 1.4364 mL
    20 mM 0.0431 mL 0.2155 mL 0.4309 mL 1.0773 mL
    25 mM 0.0345 mL 0.1724 mL 0.3447 mL 0.8618 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    Sincalide ammonium Related Classifications

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    Sincalide70706-98-8Cholecystokinin octapeptideCCK-8SQ19844CCK8CCK 8SQ 19844SQ-19844Cholecystokinin ReceptorApoptosisPI3KAktCCK ReceptorPhosphoinositide 3-kinasePKBProtein kinase BCCK‐8CCKpostevacuation cholecystographycardiovascular hormoneinflammationapoptosisPI3K/AktInhibitorinhibitorinhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Requested Quantity *

    Applicant Name *

    		 

    Salutation

    Email Address *

    		 

    Phone Number *

    Department

    		 

    Organization Name *

    City

    State

    Country or Region *

    		      

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Sincalide ammonium
    Cat. No.:
    HY-P0093A
    Quantity:
    MCE Japan Authorized Agent:

    Customer Review

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Lot #

    Applicant Name *

    		 

    Email Address *

    Phone Number

    		 

    Department *

    Organization Name *

    		 

    Country or Region *

    Remarks

    SAFETY DATA SHEET (SDS)

    English - EN (252 KB) Français - FR (252 KB) Deutsch - DE (252 KB) Norwegian - NO (252 KB) Español - ES (252 KB) Swedish - SV (252 KB) Italian - IT (252 KB) Korean - KR (252 KB) Portuguese - PT (252 KB)

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.